Article info
Coronary artery disease
Original article
High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease
- Correspondence to Robert M Stoekenbroek, Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, PO box 22660, 1100 DD, Amsterdam 1105 AZ, the Netherlands; r.m.stoekenbroek{at}amc.uva.nl
Citation
High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease
Publication history
- Received September 30, 2014
- Revised November 11, 2014
- Accepted December 5, 2014
- First published January 16, 2015.
Online issue publication
March 15, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions